Form 4: Harrow Inc. Director Adrienne Graves Reports Grant of Restricted Stock Units

Harrow Inc. Director Adrienne L. Graves reported the acquisition of 7,339 Restricted Stock Units as a compensatory award, vesting in full on June 20, 2026.

Summary

• Adrienne L. Graves, a Director of HARROW, INC. (HROW), was granted 7,339 Restricted Stock Units (RSUs).
• The RSUs were received as a compensatory award for services rendered or to be rendered.
• The award vests in full on the one-year anniversary following the grant date, which is June 20, 2026.
• The shares underlying these RSUs will not be delivered to Ms. Graves and cannot be transferred or sold until the termination of her service.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units is a standard compensatory award for a director, aligning their interests with the company's long-term performance. This is generally viewed as a positive for corporate governance and director retention.

Positives

• The grant of Restricted Stock Units aligns the director's interests with those of the shareholders, as the value of the award is tied to the company's stock performance.
• It represents a form of non-cash compensation for services, which can help conserve company cash flow.

Negatives

• The shares underlying the RSUs are not immediately deliverable and cannot be sold or transferred until the termination of service, limiting immediate liquidity for the recipient.
• The value of the award is subject to future stock price fluctuations of HARROW, INC.

Risks

• Vesting Risk: The RSUs are subject to a one-year vesting period, requiring continued service for the award to fully vest.
• Market Price Risk: The ultimate value realized from the RSUs depends on the market price of HARROW, INC. common stock at the time of share delivery, which could be lower than the current price.
• Liquidity Risk: The shares cannot be sold or transferred until termination of service, posing a liquidity constraint for the recipient.

Future Outlook

The Restricted Stock Units are scheduled to vest in full on June 20, 2026, contingent upon the director's continued service. The shares will be delivered upon termination of service.

Industry Context

The grant of Restricted Stock Units to directors is a common and widely accepted practice in publicly traded companies across various industries, including pharmaceuticals/biotechnology, to align the interests of board members with long-term shareholder value.

Comparison to Industry Standards

• The compensatory RSU award to a director is a standard practice within corporate governance and executive compensation frameworks.
• While specific comparable companies or projects are not detailed in this filing, such equity grants are typical for non-employee directors in companies of similar size and industry, aiming to incentivize long-term commitment and performance.
• The vesting schedule (one-year cliff vesting) is also a common structure for such awards.

Corporate Governance

Related Party Transactions

• Grant of 7,339 Restricted Stock Units to Adrienne L. Graves, a Director of HARROW, INC., which constitutes a related-party transaction as it involves compensation to a board member.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon share delivery, but also benefit from enhanced director alignment with long-term company performance.
• Employees: No direct impact mentioned, but reflects the company's compensation strategy for key personnel.
• Director (Adrienne L. Graves): Receives equity compensation, aligning personal financial interests with the company's stock performance, subject to vesting and service termination conditions.

Next Steps

• Vesting of 7,339 Restricted Stock Units on June 20, 2026.
• Delivery of shares underlying the Restricted Stock Units to Adrienne L. Graves upon termination of her service.

Key Dates

Keywords

HARROW, HROW, SEC Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Ownership, Corporate Governance